Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inclusion of Calcifediol in the Hospital Therapeutic Protocol for Treatment of SARS-CoV-2 Disease (COVID-19). Mortality Analysis. Retrospective Study.

NCT06279910 is registered in ClinicalTrials.gov with Complejo Hospitalario Universitario de Albacete as lead sponsor.

NCT NCT06279910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06279910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inclusion of Calcifediol in the Hospital Therapeutic Protocol for Treatment of SARS-CoV-2 Disease (COVID-19). Mortality Analysis. Retrospective Study.
Lead sponsor
Complejo Hospitalario Universitario de Albacete
Phase
Observational
Overall status
Completed
Start date
February 21, 2024
Completion date
April 25, 2024
Enrollment
230 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov 2 pneumonia